– USA, CA – Apria, Inc. (Nasdaq: APR) today announced the appointments of Susannah Gray and Terri Kline to its Board of Directors and the Audit Committee.
“With decades of combined experience in healthcare leadership and advisory, Susannah Gray and Terri Kline significantly strengthen the expertise of our Company’s Board of Directors,” said CEO, Dan Starck. “Our executive leadership and board are pleased to add two individuals with their stellar reputations, and both will undoubtedly help guide us through our next phase of growth, as we continue to strive to improve the quality of life for our patients at home.”
About Susannah Gray
Susannah Gray possesses a wealth of experience in healthcare leadership, serving in the board of director and committee capacities at 4D Molecular Therapeutics, Maravai Life Sciences, Morphic Therapeutics, BioSplice Therapeutics, Wesleyan University, the Susan G. Komen Foundation, Street Squash, and the German Marshall Fund. She also served as EVP and CFO of Royalty Pharma, the largest aggregator of pharmaceutical royalty interests worldwide, and held roles at Chase Securities, Merrill Lynch, and CIBC World Markets.
Susannah Gray holds a Master of Business Administration from Columbia University and a Bachelor of Arts from Wesleyan University.
About Terri Kline
Terri Kline brings to Apria deep expertise in healthcare advisory and currently serves on the boards of Amedisys, Intersect ENT, SaVida Health, and Presbyterian Health Plan, Inc. Previously, she served as Executive Vice President of Henry Ford Health System, as President and CEO of Health Alliance Plan – a subsidiary of HFHS – and as SVP and Chief Health Care Management Officer of Health Care Service Corporation.
Terri Kline holds a Master of Public Health from the University of Michigan and a Bachelor of Arts from Kalamazoo College.
About Apria
Apria is a leading provider of integrated home healthcare equipment and related services in the United States. The Company offers a comprehensive range of products and services for in-home care and delivery across three core service lines: (1) home respiratory therapy (including home oxygen and non-invasive ventilation services); (2) obstructive sleep apnea treatment (including continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services); and (3) negative pressure wound therapy. Additionally, the Company supplies a wide range of home medical equipment and other products and services to help improve the quality of life for patients with home care needs. Our revenues are generated through fee-for-service and capitation arrangements with payors for equipment, supplies, services, and other items we rent or sell to patients. Through our offerings, we also provide patients with a variety of clinical and administrative support services and related products and supplies, most of which are prescribed by a physician as part of a care plan. We are focused on being the industry’s highest-quality provider of home healthcare equipment and related services while maintaining our commitment to being a low-cost operator. The Company serves over 2 million patients annually and offers a compelling value proposition to patients, providers, and payors by allowing patients to receive necessary care and services in the comfort of their own home, while, at the same time, reducing the costs of treatment.
For more information: https://www.apria.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.